789 related articles for article (PubMed ID: 25650401)
1. α-2,3-sialyltransferase expression level impacts the kinetics of lipooligosaccharide sialylation, complement resistance, and the ability of Neisseria gonorrhoeae to colonize the murine genital tract.
Lewis LA; Gulati S; Burrowes E; Zheng B; Ram S; Rice PA
mBio; 2015 Feb; 6(1):. PubMed ID: 25650401
[TBL] [Abstract][Full Text] [Related]
2. The Lst Sialyltransferase of Neisseria gonorrhoeae Can Transfer Keto-Deoxyoctanoate as the Terminal Sugar of Lipooligosaccharide: a Glyco-Achilles Heel That Provides a New Strategy for Vaccines to Prevent Gonorrhea.
Jen FE; Ketterer MR; Semchenko EA; Day CJ; Seib KL; Apicella MA; Jennings MP
mBio; 2021 Mar; 12(2):. PubMed ID: 33758087
[TBL] [Abstract][Full Text] [Related]
3.
Cardenas AJ; Thomas KS; Broden MW; Ferraro NJ; Pires MM; John CM; Jarvis GA; Criss AK
mBio; 2024 May; 15(5):e0011924. PubMed ID: 38587424
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic CMP-Nonulosonates against Multidrug-Resistant
Gulati S; Schoenhofen IC; Lindhout-Djukic T; Schur MJ; Landig CS; Saha S; Deng L; Lewis LA; Zheng B; Varki A; Ram S
J Immunol; 2020 Jun; 204(12):3283-3295. PubMed ID: 32434942
[No Abstract] [Full Text] [Related]
5. The Neisseria lipooligosaccharide-specific alpha-2,3-sialyltransferase is a surface-exposed outer membrane protein.
Shell DM; Chiles L; Judd RC; Seal S; Rest RF
Infect Immun; 2002 Jul; 70(7):3744-51. PubMed ID: 12065517
[TBL] [Abstract][Full Text] [Related]
6. Enhanced factor H binding to sialylated Gonococci is restricted to the sialylated lacto-N-neotetraose lipooligosaccharide species: implications for serum resistance and evidence for a bifunctional lipooligosaccharide sialyltransferase in Gonococci.
Gulati S; Cox A; Lewis LA; Michael FS; Li J; Boden R; Ram S; Rice PA
Infect Immun; 2005 Nov; 73(11):7390-7. PubMed ID: 16239538
[TBL] [Abstract][Full Text] [Related]
7. A Novel Sialylation Site on Neisseria gonorrhoeae Lipooligosaccharide Links Heptose II Lactose Expression with Pathogenicity.
Ram S; Gulati S; Lewis LA; Chakraborti S; Zheng B; DeOliveira RB; Reed GW; Cox AD; Li J; St Michael F; Stupak J; Su XH; Saha S; Landig CS; Varki A; Rice PA
Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29844237
[TBL] [Abstract][Full Text] [Related]
8. Utilizing CMP-Sialic Acid Analogs to Unravel Neisseria gonorrhoeae Lipooligosaccharide-Mediated Complement Resistance and Design Novel Therapeutics.
Gulati S; Schoenhofen IC; Whitfield DM; Cox AD; Li J; St Michael F; Vinogradov EV; Stupak J; Zheng B; Ohnishi M; Unemo M; Lewis LA; Taylor RE; Landig CS; Diaz S; Reed GW; Varki A; Rice PA; Ram S
PLoS Pathog; 2015 Dec; 11(12):e1005290. PubMed ID: 26630657
[TBL] [Abstract][Full Text] [Related]
9. Anaerobic growth and cytidine 5'-monophospho-N-acetylneuraminic acid act synergistically to induce high-level serum resistance in Neisseria gonorrhoeae.
Frangipane JV; Rest RF
Infect Immun; 1993 May; 61(5):1657-66. PubMed ID: 8478054
[TBL] [Abstract][Full Text] [Related]
10. Alpha-2,3-sialyltransferase enhances Neisseria gonorrhoeae survival during experimental murine genital tract infection.
Wu H; Jerse AE
Infect Immun; 2006 Jul; 74(7):4094-103. PubMed ID: 16790783
[TBL] [Abstract][Full Text] [Related]
11. Functional characterization of an isogenic meningococcal alpha-2,3-sialyltransferase mutant: the role of lipooligosaccharide sialylation for serum resistance in serogroup B meningococci.
Vogel U; Claus H; Heinze G; Frosch M
Med Microbiol Immunol; 1997 Oct; 186(2-3):159-66. PubMed ID: 9403845
[TBL] [Abstract][Full Text] [Related]
12. Differential expression and transcriptional analysis of the alpha-2,3-sialyltransferase gene in pathogenic Neisseria spp.
Packiam M; Shell DM; Liu SV; Liu YB; McGee DJ; Srivastava R; Seal S; Rest RF
Infect Immun; 2006 May; 74(5):2637-50. PubMed ID: 16622200
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a sialyltransferase-deficient mutant of Neisseria gonorrhoeae strain F62: instability of transposon Tn1545 delta3 in gonococci and evidence that multiple genetic loci are essential for lipooligosaccharide sialylation.
Crooke H; Griffiss JM; John CM; Lissenden S; Bramley J; Regan T; Smith H; Cole J
Microb Pathog; 1998 Nov; 25(5):237-52. PubMed ID: 9878453
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Antigonococcal CMP-Nonulosonate Therapeutics Require Cathelicidins.
Gulati S; Schoenhofen IC; Lindhout-Djukic T; Lewis LA; Moustafa IY; Saha S; Zheng B; Nowak N; Rice PA; Varki A; Ram S
J Infect Dis; 2020 Oct; 222(10):1641-1650. PubMed ID: 32692363
[TBL] [Abstract][Full Text] [Related]
15. Regulation of gonococcal sialyltransferase, lipooligosaccharide, and serum resistance by glucose, pyruvate, and lactate.
McGee DJ; Rest RF
Infect Immun; 1996 Nov; 64(11):4630-7. PubMed ID: 8890217
[TBL] [Abstract][Full Text] [Related]
16. The (alpha2-->8)-linked polysialic acid capsule and lipooligosaccharide structure both contribute to the ability of serogroup B Neisseria meningitidis to resist the bactericidal activity of normal human serum.
Kahler CM; Martin LE; Shih GC; Rahman MM; Carlson RW; Stephens DS
Infect Immun; 1998 Dec; 66(12):5939-47. PubMed ID: 9826376
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of conversion of Neisseria gonorrhoeae to resistance to complement by cytidine 5'-monophospho-N-acetyl neuraminic acid.
Emond JP; Dublanchet A; Goldner M
Antonie Van Leeuwenhoek; 1995; 67(3):281-8. PubMed ID: 7778896
[TBL] [Abstract][Full Text] [Related]
18. Effect of exogenous sialylation of the lipooligosaccharide of Neisseria gonorrhoeae on opsonophagocytosis.
Kim JJ; Zhou D; Mandrell RE; Griffiss JM
Infect Immun; 1992 Oct; 60(10):4439-42. PubMed ID: 1398958
[TBL] [Abstract][Full Text] [Related]
19. Detection of the lst gene in different serogroups and LOS immunotypes of Neisseria meningitidis.
Tsang RS; Law DK; Tsai C; Ng L
FEMS Microbiol Lett; 2001 May; 199(2):203-6. PubMed ID: 11377868
[TBL] [Abstract][Full Text] [Related]
20. Incorporation of N-acetylneuraminic acid into Haemophilus somnus lipooligosaccharide (LOS): enhancement of resistance to serum and reduction of LOS antibody binding.
Inzana TJ; Glindemann G; Cox AD; Wakarchuk W; Howard MD
Infect Immun; 2002 Sep; 70(9):4870-9. PubMed ID: 12183531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
